Table 1.
iOAT titration schedule and maintenance doses of self-administered IV or IM hydromorphone in two doses daily
Case 1 | Case 1 | Case 2 | Case 3 | |||||
---|---|---|---|---|---|---|---|---|
Titration #1 |
Titration #2 |
|||||||
Dose #1 | Dose #2 | Dose #1 | Dose #2 | Dose #1 | Dose #2 | Dose #1 | Dose #2 | |
Titration | ||||||||
Day 1 | 20 | 20 | 45+30* | 50+30* | 15+30* | 45+10* | 15+30* | 45+30* |
Day 2 | 40 | 60 | 80+20* | 100 | 45+30* | 50+30* | 50+30* | 80+20* |
Day 3 | 60 | 80 | 100 | 100 | 80 | 80 | 100 | 100 |
Day 4 | 80 | 90 | - | - | - | - | - | - |
Day 5 | 90 | 90 | - | - | - | - | - | - |
Maintenance | ||||||||
Hydromorphone IV | 90 | 90 | 140 | 140 | 60 | 60 | 150 | 150 |
Oral OAT (SROM) | - | 400 | 600 | 400 |
All doses in milligrams (mg). Doses are at least 3 hours apart with 20 minute post-dose observation period.
Top-up doses given 20 minutes later if no signs of intoxication based on clinical judgement by nurse or physician and discussion with patient.